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The UDP-Glc:glycoprotein glucosyltransferase (GT), a
key player in the endoplasmic reticulum (ER) quality
control of glycoprotein folding, only glucosylates glyco-
proteins displaying non-native conformations. To deter-
mine whether GT recognizes folding intermediates or
irreparably misfolded species with nearly native struc-
tures, we generated and tested as GT substrates neogly-
coprotein fragments derived from chymotrypsin inhibi-
tor 2 (GCI2) bearing from 53 to 64 (full-length) amino
acids. Fragment conformations mimicked the last stage-
folding structures adopted by a glycoprotein entering
the ER lumen. GT catalytic efficiency (Vmax/Km) re-
mained constant from GCI2-(1–53) to GCI2-(1–58) and
then steadily declined to reach a minimal value with
GCI2-(1–64). The same parameter showed a direct hy-
perbolic relationship with solvent accessibility of the
single Trp residue but only in fragments exposing hy-
drophobic amino acid patches. Mutations introduced
(GCI2-(1–63)V63S and GCI2-(1–64)V63S) produced slight
structural destabilizations but increased GT catalytic
efficiency. This parameter presented an inverse expo-
nential relationship with the free energy of unfolding of
canonical and mutant fragments. Moreover, the cata-
lytic efficiency showed a linear relationship with the
fraction of unfolded species in water. It was concluded
that the GT-derived quality control may be operative
with nearly native conformers and that no alternative
ER-retaining mechanisms are required when glycopro-
teins approach their proper folding.
A quality control mechanism in the endoplasmic reticulum
(ER)1 is in charge of sensing the folding state of glycoproteins
before their transport to the Golgi apparatus (1). Proteins incor-
rectly folded are initially retained in the ER and eventually
degraded by the proteasome, a process known as ER-associated
degradation (2, 3). Recent findings on glycoprotein processing in
the ER showed that sugar moieties could be exploited to encode
information on glycoprotein folding status. About 65% of Asn-X-
Ser/Thr consensus sequences in proteins entering the ER lumen
are N-glycosylated (4). The Glc3Man9GlcNAc2 glycan transferred
is deglucosylated immediately by the sequential action of gluco-
sidases I and II. At this stage the proteins that are not correctly
folded are reglucosylated by UDP-Glc:glycoprotein glucosyltrans-
ferase (GT), generating Glc1Man9GlcNAc2. This enzyme has a
unique property as it glucosylates glycoproteins displaying na-
tive-close, molten globule-like but not random coil or compact-
native conformations. Monoglucosylated glycans are specifically
recognized by two ER resident lectins, calnexin (CNX) and cal-
reticulin (CRT), in charge of retaining folding intermediates and
irreparably misfolded glycoproteins in the ER. In addition, lectin
binding facilitates conformational maturation of glycoproteins by
preventing aggregation and allowing the labor of lectin-associ-
ated proteins such as ERp57 (endoplasmic reticulum protein 57),
a protein of the protein disulfide isomerase family (5).
The single glucose added by GT is removed in vivo by gluco-
sidases I and II, whose activity is independent of the folding
status of glycoproteins, causing the release of the latter from
the lectin anchors. The ensuing shuttle between Glc-contain-
ing, lectin-bound, and Glc- and lectin-free species, catalyzed by
the opposing activities of GT and glucosidases I and II ends on
acquisition of native compact conformations. The selectivity of
this cycle for misfolded proteins resides in GT, since it is the
only element of the mechanism that senses glycoprotein con-
formational states. This quality control mechanism is not the
only one operating in the ER as there are alternative mecha-
nisms for retaining proteins not displaying their fully folded
structures, as those involving other conventional chaperones,
such as BiP/Grp78 or reversible disulfide bonding with ER
resident proteins (1).
Because GT reglucosylates a myriad of misfolded glycopro-
teins, the molecular determinants for glycoprotein recognition
should be, in principle, independent of the primary structure
and should rest upon elements common to irreparably mis-
folded or partially folded structures. Current evidence points to
exposure of hydrophobic residues as the common determinant
(6, 7). In a recent work we presented evidence showing that GT
recognized local stretches of hydrophobic residues in small
disordered fragments rather poorly but actively glucosylated
glycoproteins showing long range interactions in molten glob-
ule-like conformations, thus, exposing anilinonaphthalene sul-
fonic acid (ANS) binding hydrophobic patches (8).
It remained to be established, however, if the enzyme is sen-
sitive enough to glucosylate glycoproteins with minimal struc-
tural differences with respect to native conformations. Inability
to glucosylate nearly native conformations would mean that al-
ternative retaining systems must replace CNX and CRT at the
end of the folding process or in irreparably misfolded species,
showing conformations slightly differing from native ones. To
* This work was supported by National Institutes of Health Grant
RO1 GM44500/13, the Howard Hughes Medical Institute, and the
Agencia Nacional de Promocio´n Cientı´fica y Te´cnica (Argentina). The
costs of publication of this article were defrayed in part by the payment
of page charges. This article must therefore be hereby marked “adver-
tisement” in accordance with 18 U.S.C. Section 1734 solely to indicate
this fact.
‡ To whom correspondence should be addressed: Fundacio´n Instituto
Leloir, Avda. Patricias Argentinas 435, Buenos Aires, Argentina
C1405BWE. Tel.: 54-11-4863-4012; Fax: 54-11-4865-2246; E-mail:
aparodi@leloir.org.ar.
1 The abbreviations used are: ER, endoplasmic reticulum; ANS,
anilinonaphthalene sulfonic acid; BiP/Grp78, binding protein/glu-
cose-regulated protein 78, an endoplasmic reticulum chaperone of the
Hsp70 family; CI2, chymotrypsin inhibitor 2; CNX, calnexin; CRT,
calreticulin; GCI2, glycosylated chymotrypsin inhibitor 2; Grp94, glu-
cose-regulated protein 94, an endoplasmic reticulum chaperone of the
Hsp90 family; GT, UDP-Glc:glycoprotein glucosyltransferase;
Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 279, No. 44, Issue of October 29, pp. 46280–46285, 2004
© 2004 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org46280
address this issue we have now correlated GT catalytic efficiency
with structures of neoglycoproteins of increasing sizes approach-
ing that of the full-length species, thus mimicking the last folding
conformations adopted by a glycoprotein entering the ER lumen.
We, thus, found that GT is an exquisite sensor of the thermody-
namic stability of nearly native structures that are to be retained
for quality control iteration.
EXPERIMENTAL PROCEDURES
Materials—All chemicals were purchased from Sigma with the ex-
ception of sulfosuccinimidyl 4-(N-maleimidomethyl)cyclohexane-1-car-
boxylate, which was purchased from Pierce, and NAP-5 desalting col-
umns, from Amersham Biosciences. Rat liver GT was purified as
described (9). UDP-[14C]Glc (300 mCi/mmol) was synthesized as previ-
ously described (9).
Expression, Purification, and Glycosylation of Chymotrypsin Inhibi-
tor 2 (CI2)—This study is based on the truncated form of CI2, where the
first residue corresponds to Met-20 (10). CI2-(1–25), CI2-(1–40), and
CI2-(1–64) were obtained as described previously (8). The remaining
fragments were produced by introducing a stop codon at the appropriate
positions by the inverse PCR method using the pTZ18U-based vector
(11). We also introduced the substitution E7C to chemically glycosylate
the proteins. Transformed Escherichia coli TG2 cultures at OD 1 were
induced overnight with 1 mM isopropylthiogalactoside. Cells were har-
vested, resuspended in 1⁄20volume of 50 mM Tris-HCl buffer, pH 8.0, 2
mM EDTA, 1 mM phenylmethanesulfonyl fluoride, 0.1% Triton X-100,
and 50 g/ml lysozyme. After incubation at room temperature for 30
min, cells were placed in an ice bath and sonicated twice for 1 min with
a Virsonic 550 sonicator; CI2s were found mainly in inclusion bodies
after centrifugation at 16,000 rpm for 30 min. The inclusion bodies were
washed three times with 20 ml of 50 mM Tris-HCl buffer, pH 8.0, 10 mM
EDTA, 0.5% Triton X-100, and 100 mM NaCl and then 50 mM Tris-HCl
buffer, pH 8.0, 10 mM EDTA, 0.5% Triton X-100, 0.5 M guanidinium-
HCl, and 5 mM -mercaptoethanol. Finally, inclusion bodies were sol-
ubilized with 15 ml of 50 mM Tris-HCl buffer, pH 8.0, 5 mM EDTA, and
6 M urea. After centrifugation for 30 min at 16,000 rpm the solutions
were applied to a Superdex-75 HR16/50 column and eluted with 50 mM
Tris-HCl buffer, pH 8.0, 4 M urea, and 150 mM NaCl. Fractions contain-
ing CI2s were pooled. Trifluoroacetic acid and acetonitrile were added
to a final concentration of 0.05 and 5%, respectively. Proteins were
purified by reverse phase high performance liquid chromatography
using a Vydac C8 column with a linear gradient of acetonitrile/water in
0.1% trifluoroacetic acid and dried in a SpeedVac. Because GT sub-
strates are high mannose-type glycoproteins, thyroglobulin/Pronase-
derived high mannose-type glycopeptides were covalently linked to the
new-engineered C7 compounds by using sulfosuccinimidyl 4-(N-male-
imidomethyl)cyclohexane-1-carboxylate as described previously (8).
Glycosylated CI2s will be referred to as GCI2s.
Spectroscopic Characterization of GCI2s—CD spectra were meas-
ured with a Jasco J810 spectropolarimeter. We used 10 M GCI2s in far
UV and 40 M in near UV CD. Intrinsic fluorescence and ANS binding
were measured with an Aminco Bowman Series 2 spectrofluorimeter
with 5 M GCI2s. We used 50 M ANS with the excitation wavelength
set at 360 nm and spectra recorded from 400 to 650 nm. All spectra were
recorded at 25 °C in 20 mM HEPES buffer, pH 7.4.
Protein Stability—Chemical denaturation experiments were per-
formed as described (10). Fluorescence spectra were detected with the
excitation wavelength set at 280 nm, and spectra were recorded from
300 to 430 nm. Excitation and emission band passes were 8 and 2 nm,
respectively. The fluorescence spectra center of mass values were used
to describe the conformational states.
Activity Assays—GT assays were carried out at 37 °C in 30 l of 40 mM
HEPES buffer, pH 7.4, 20 mM KCl, 5 mM CaCl2, and 15 M UDP-Glc
(100,000 cpm of UDP-[14C]Glc, 300 mCi/mmol). Reactions were started by
the addition of 2 g of rat liver GT and stopped after 10 min by the
addition 30 l of cracking buffer at 100 °C containing 5% SDS. The
samples were immediately heated for 10 min at 90 °C. An aliquot of 15 l
was run in Tricine-SDS-PAGE electrophoresis (12). The dried gel was
exposed to an LE phosphor screen (Amersham Biosciences) for 12 h and
revealed in a Storm 820 PhosphorImager. A linear relationship between
density and radioactivity was obtained under conditions described.
RESULTS
Description of the Model Neoglycoprotein System Employed—
CI2 is an extremely useful model to study chaperone and GT
recognition of nascent chains (8). However, because GT sub-
strates are glycoproteins, the original E7 in CI2 was replaced
by a cysteine (E7C) to which a high mannose-type glycopeptide
derived from bovine thyroglobulin was attached through a bi-
functional chemical cross-linker (glycosylated CI2s are to be
referred to as GCI2s). The original glutamic acid residue is in a
type III turn resembling many natural N-glycosylation sites
(4). It is exposed to the solvent and has no effect on full-length
CI2 conformation (13). We had previously determined that a
significant GT activity was only attained with the fragment of
53 residues in length, the first ones to display long range native
interactions (8). We now focused on GCI2 fragments having
from 53 to 64 (full-length) amino acid residues. Their confor-
mations mimic the last folding structures adopted by a glyco-
protein entering the ER lumen. The acquisition of the native
structure in CI2 is highly cooperative with the addition of the
last two residues (Val-63 and Gly-64) (14). Although partially
exposed to the solvent, Val-63 interacts with Val-47 and Trp-5
(the only tryptophan residue in CI2) in the hydrophobic core,
whereas Gly-64 does so with Arg-46 and Arg-48 through ionic
interactions (Fig. 1) (13). A point mutation (V63S) was also
introduced because previous experiments had shown that cer-
tain mutations at that position have a destabilizing effect on
CI2-(1–64) native structure (15).
Structural Characterization of Last Folding Intermediates—
The center of mass of fluorescence spectra of GCI2s revealed
almost no variation of tryptophan exposure to the solvent as
the chain grew from GCI2-(1–53) to GCI2-(1–62), with an ab-
rupt change upon the addition of the last two residues where
the tryptophan side chain appears completely buried (Fig. 2A).
Both GCI2-(1–63)V63S and GCI2-(1–64)V63S fluorescence
spectra showed a shift toward longer wavelengths with respect
to the canonical derivatives having Val-63. Far UV CD spectra
presented only a marginal variation for derivatives ranging
from GCI2-(1–53) to GCI2-(1–62), thus indicating almost no
effect of the chain length on the secondary structure within
that size range (Fig. 2B; only the GCI2-(1–53) is shown). On the
contrary, a somewhat different spectrum was observed in
GCI2-(1–64), whereas GCI2-(1–63), GCI2-(1–63)V63S, and
GCI2-(1–64)V63S presented intermediate patterns between
those of GCI2-(1–53) to GCI2-(1–62) and GCI2-(1–64).
Although derivatives ranging from GCI2-(1–53) to GCI2-(1–
63) displayed very similar near UV CD spectra (Fig. 2C; only
those of GCI2-(1–53), GCI2-(1–63), and GCI2-(1–63)V63S are
shown), those of GCI2-(1–64) and GCI2-(1–64)V63S were
sharply different as they displayed a positive band at about 290
nm. This implied that the full-length neoglycoproteins had the
Trp-5 residue located in an asymmetric environment indicative
of defined three dimensional structures, in contrast with
shorter fragments. In addition, only non-full-length species
showed ANS binding, although GCI2-(1–64)V63S gave a
slightly positive signal when compared with GCI2-(1–64) or
FIG. 1. Structure of CI2. Adapted from McPhalen and James (13).
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the buffer (Fig. 2D; although not shown, GCI2-(1–53) to GCI2-
(1–62) also showed ANS binding). ANS is a sensitive probe for
the presence of accessible hydrophobic patches. It was con-
cluded that the onset of native secondary and tertiary structure
in GCI2s takes place in parallel when 83% of sequence infor-
mation is attained (GCI2-(1–53) and that the acquisition of the
compact cooperatively folded native structure occurs only upon
the addition of the last two residues.
Additional Structural Features of Mutant Neoglycopro-
teins—Chemical denaturation of GCI2-(1–63)V63S, GCI2-(1–
64)V63S, and of their canonical homologues with guanidinium
hydrochloride showed how the V63S mutation and removal of
Gly-64 affected the stability of the parental proteins (Fig. 2E).
The stability of GCI2-(1–64) and GCI2-(1–63) diminished by
1.3 and 0.2 kcal/mol, respectively, upon introduction of muta-
tions (Table I). The destabilizing effect was more pronounced
for the full-length protein, since cleavage of the C-terminal
residue has a higher destabilizing effect than the V63S muta-
tion. As we mentioned above, CI2 structure is stabilized
through ionic interactions from the C terminus to Arg-46 and
Arg-48. The stability differences between wild type and mu-
tated same-length derivatives parallels the shift to longer
wavelengths in the fluorescence spectra and the increased ANS
binding of the mutants.
GT Recognizes Native-close Conformations of GCI2 Neogly-
coproteins—Quantitative kinetic experiments with GT were
performed because the GCI2 family remained soluble within
wide concentration ranges. As shown in Fig. 3A GCI2-(1–63)
and GCI2-(1–64) were much poorer substrates than the shorter
fragments (values yielded by fragments not shown fell between
those of GCI2-(1–53) and GCI2-(1–63)V63S). The glucose ac-
ceptor capacities of GCI2-(1–63)V63S and GCI2-(1–64)V63S
were higher than those of the respective canonical fragments
(GCI2-(1–63) and GCI2-(1–64). Because the C-terminal resi-
FIG. 2. Structural characterization of GCI2-(1–53), GCI2-(1–58), GCI2-(1–60), GCI2-(1–61), GCI2-(1–62), GCI2-(1–63), GCI2-(1–64),
GCI2-(1–63)V63S, and GCI2-(1–64)V63S. A, fluorescence center of mass versus chain length. B, far UV CD of selected GCI2s. Non-indicated
curves are similar to GCI2-(1–53). C, near UV CD of selected CI2s. Non-indicated curves lie between those of GCI2-(1–53) and GCI2-(1–63). D, ANS
binding. Spectra not shown resemble that of GCI2-(1–63). AU, arbitrary units. E, unfolding of indicated neoglycoproteins with increasing
guanidinium hydrochloride (GdnHcl) concentrations.
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due in GCI2-(1–64) is a glycine, the decrease in GT activity
from GCI2-(1–63) to GCI2-(1–64) is not an outcome from its
inhibition by a particular amino acid side chain at the C-
terminal position but, rather, is a consequence of the effect of
this residue on the global structure of GCI2. All efficient sub-
strates bound ANS, supporting the idea that GT recognizes the
exposition of the hydrophobic core. The slightly higher glucose
acceptor capacity of GCI2-(1–64)V63S with respect to GCI2-(1–
64) also correlated with a slightly higher ANS binding capacity
(Fig. 2D). It is worth mentioning that we had previously re-
ported that neither GCI2-(1–25), GCI2-(1–40), nor GCI2-(1–
64) bind ANS and were poorly or not glucosylated by GT (8).
The GT catalytic efficiency expressed as Vmax/Km showed a
clear trend when expressed as a function of the chain length
(Fig. 3B); no significant variation was observed from GCI2-(1–
53) to GCI2-(1–58), but a sharp decrease appeared from this
species to GCI2-(1–64). Note the higher catalytic efficiency
detected with GCI2-(1–63)V63S and GCI2-(1–64)V63S as sub-
strates when compared with the respective canonical com-
pounds. The catalytic efficiency showed a direct hyperbolic
relationship with the exposure of the hydrophobic core as indi-
cated by the intrinsic fluorescence mass center values (Fig. 3C;
values for GCI2-(1–25) and GCI2-(1–40) were taken from Cara-
melo et al. (8)). Points corresponding to GCI2-(1–25) and GCI2-
(1–40) fell outside the curve. As previously determined, those
fragments display disordered conformations lacking ANS bind-
ing hydrophobic patches, although their Trp-5 residues are
solvent-exposed. Results observed reflected, therefore, the loss
of GT recognition upon progressive consolidation of the sub-
strate compact fold.
GT Senses the Thermodynamic Stability of Close to Native
Folding Intermediates—The free energy of unfolding of GCI2-
(1–63)V63S, GCI2-(1–64)V63S, and of their wild type, same-
length homologues revealed an inverse exponential depend-
ence with GT catalytic efficiencies (Fig. 4A). The free energy of
unfolding values of wild type and mutant neoglycoproteins
covered a rather wide range, from 1.7 to 4.7 kcal/mol, the last
of which closely resembles values observed for medium size
TABLE I
Unfolding parameters of neoglycoproteins
m in column 2 refers to the constant from the equation G[GdnHCl]  GH20  m[GdnHCl], where G[GdnHCl] (GdnHCl is guanidinium
hydrochloride) and GH20 are the free energies of folding in water and at a given denaturant concentration.
GH20 m GdnHCl50
kcal mol1 kcal mol1 M1 M
GCI2-(1–64) 4.7  0.1 1.28  0.05 3.7  0.2
GCI2-(1–64)V63S 3.4  0.1 1.10  0.03 3.1  0.1
GCI2-(1–63) 1.9  0.1 0.92  0.02 2.1  0.1
GCI2-(1–63)V63S 1.7  0.1 1.7  0.1 1.0  0.1
FIG. 3. GT activity. A, GT activity with different neoglycoproteins as acceptor substrates. Curves not shown lie between those of GCI2-(1–62)
and GCI2-(1–53). B, GT catalytic efficiency (Vmax/Km) versus chain length. Inset, catalytic efficiency versus chain length from GCI2-(1–25) to
GCI2-(1–64). C, GT catalytic efficiency versus fluorescence center of mass. Both in this panel and in the inset data for GCI2-(1–25) and GCI2-(1–40)
were taken from Caramelo et al. (8).
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monomeric proteins. Notably, the catalytic efficiencies showed
a linear relationship with the population fraction of unfolded
GCI2 in water (Fig. 4B; the fractions of unfolded GCI2s were
calculated assuming similar free energy values for the unfolded
states of all four neoglycoproteins). Results presented in Figs.
4, A and B, suggest that perhaps GT is one of the most exquisite
biosensors of the stability of protein conformations described
to date.
DISCUSSION
In a previous report we studied the glucose acceptor capaci-
ties of four neoglycoproteins, GCI2-(1–25), GCI2-(1–40), GCI2-
(1–53), and GCI2-(1–64) (8), an unstructured hydrophilic pep-
tide, a hydrophobic peptide devoid of long range interactions, a
molten globule-like, and a properly folded species, respectively.
The onset of secondary and tertiary native structure occurs in
GCI2-(1–53), which was the best GT substrate, and we con-
cluded that the enzyme preferentially recognized solvent-acces-
sible hydrophobic regions present in native-like conformations
that have not reached their final compact state. Results here
reported further extend our observations to additional com-
pounds and confirm our previous conclusion, as GT catalytic
efficiency showed a hyperbolic relationship with tryptophan
intrinsic fluorescence center of mass but only in ANS binding
(i.e. exposing hydrophobic patches) compounds (Fig. 3C). For
instance GCI2-(1–40), despite displaying a stretch of highly
hydrophobic amino acid residues from positions 26 to 39, lacked
long range interactions, did not bind ANS, and consequently
was a rather poor GT substrate. Furthermore, relationships of
catalytic efficiency (Fig. 3B, inset) or ANS fluorescence of CI2s
(Fig. 5 in de Prat Gay et al. (14)) with chain length were
practically super imposable. Of the several features of a molten
globule conformation (mobility of the polypeptide chain, pres-
ence of secondary and tertiary structural elements, free access
of the glycan to the solvent, exposure of hydrophobic amino acid
patches, etc.) only the latter is not shared with GCI2s that are
poor GT substrates.
GT glucosylated neoglycoproteins of increasing length until
the substrate displayed its full size, thus acquiring its native
compact structure. However, because folding of the neoglyco-
proteins employed is highly cooperative with the acquisition of
the last two residues (14), it may be argued that in other
systems in which the three-dimensional structure of fragments
lacking a few residues at their C terminus does not signifi-
cantly differ from that of the full-length species, glucosylation
might stop before acquisition of the native structure at its most
minimal details. To test this possibility we introduced a point
mutation in the amino acid before last (V63S), known to induce
a minimal structural perturbation (15). Although the far UV
CD spectra of GCI2-(1–64) and GCI2-(1–64)V63S showed only
slight variations and changes observed for near UV CD spectra
were minimal as also were their intrinsic fluorescence mass
center values and the extent of ANS binding and that the
energy of unfolding only showed a respective decrease from 4.7
to 3.4 kcal/mol, both compounds were differentially glucosy-
lated by GT. Similarly, although the free energy of unfolding of
GCI2-(1–63) and GCI2-(1–63)V63S only differed by 0.2 kcal/
mol, both neoglycoproteins were glucosylated with sharply dif-
ferent catalytic efficiencies. In fact, GT catalytic efficiency
showed a linear dependence with the proportion of unfolded
GCI2 in water. This last parameter may be taken as an indi-
cation of the dynamic behavior of GCI2 as a higher value would
indicate that a molecule occurs for longer time periods in pu-
tative unfolded conformations. The exquisite way by which GT
senses the stability of glycoproteins ensures that no species
displaying minimally incomplete three-dimensional structures
would leave the ER. The ability of GT to discriminate between
minimally differing three-dimensional structures has been re-
cently documented also (7). Introduction of a point mutation
(F280S) to exo-(1,3)--glucanase elicited recognition of the gly-
coprotein by GT presumably without significantly affecting its
three-dimensional structure, as the protein remained enzymat-
ically active.
At this point we can visualize a complete picture of GT
recognition of a single folding protein domain emerging into the
ER lumen (inset in Fig. 3B). CI2-(1–64) has two potential
BiP/Grp78 binding sites, one of them centered at Trp-5 and the
other at Leu-32, the last one within a stretch of highly hydro-
phobic residues. Whereas the first one is abolished on linking
the glycopeptide to C7, the second site remains active after
glycan addition as GCI2-(1–40) (but not GCI2-(1–25) sharply
enhanced BiP/Grp78 intrinsic ATPase activity (8). Moreover, a
molten globule-like conformation displaying optimal glucose
acceptor capacity is not attained until the molecule has about
83% of its sequence information. The protein entering the ER
lumen would then be N-glycosylated at position seven, recog-
nized by BiP/Grp78 when about 35–40 amino acids are already
in the lumen, and collapse on reaching a 50–53-amino acid
length. Formation of the molten globule-like structure will then
prevent BiP/Grp78 binding because this chaperone recognizes
heptapeptides with aliphatic hydrophobic amino acids in alter-
FIG. 4. Relationship between GT catalytic efficiency and neoglycoprotein structural features. A, GT catalytic efficiency versus
unfolding free energy (Gunf). B, GT catalytic efficiency versus fraction of unfolded neoglycoproteins in water (fuH20).
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nating positions in proteins displaying extended conforma-
tions. As expected, GCI2-(1–53) triggered a much lower BiP/
Grp78 ATPase activity than GCI2-(1–40), although both
neoglycoproteins shared the same Grp/BiP binding site cen-
tered at Leu-32 (8). It is doubtful that immediate partial de-
glucosylation of the transferred glycan mediated by glucosi-
dases I and II would elicit a long-lived CNX/CRT-GCI2
interaction; because affinity of lectins for monoglucosylated
glycans is rather low (16), it would be expected that an initial
lectin binding would be followed by dissociation of the complex
and glucosidases I- and II-mediated complete deglucosylation.
No further glucosylation and, hence, CNX/CRT binding would
occur until formation of molten globule-like conformations.
Formation of these last conformations would then result in
glucosylation-deglucosylation cycles lasting until the native
structure at its most minimal details is attained. This inter-
pretation is somewhat at odds with the in vivo observation that
glycoproteins bearing an N-glycan within the first 50 amino
acids would interact with CNX/CRT and not with BiP/Grp78
(17). A short-lived interaction with the latter chaperone, per-
haps not detectable by immunoprecipitation as it would last as
the protein grows from about 35–40 until it reaches 50–53
amino acids, can conceivably take place. Furthermore, the se-
quential interaction, first with BiP/Grp78 and then with CNX/
CRT, has been documented for several glycoproteins (17–20).
How does GT recognize nascent polypeptide substrates? We
have previously determined that GT has at least two independ-
ent folding domains located at the N- and C-terminal ends,
comprising 80 and 20% of the molecule, respectively. Both
domains remained tightly but not covalently bound upon a mild
proteolytic treatment, after which they could not be separated
by common biochemical procedures without loss of enzymatic
activity (21). The C-terminal portion is the catalytic domain as
it shares sequence similarity and the ability to bind UDP-Glc
analogs with glycosyltransferase family 8 enzymes (22). On the
other hand, there is strong evidence suggesting that the N-
terminal domain is the portion recognizing the folding status of
glycoprotein substrates in addition to being required for the
C-terminal domain stability (21, 23). It may be speculated that
on GT recognition of molten globule-like structures, the contact
surface between N- and C-terminal domains becomes somehow
partially distorted, thus, allowing binding of the substrate gly-
coprotein hydrophobic surface. This is highly reminiscent to
what happens on Grp94 recognition of folding intermediates.
Grp94 is an ER chaperone that, unlike BiP/Grp78 and the same
as GT, recognizes proteins in advanced folding stages. It has
been established that Grp94 is a dimer and that the contact
surface between both monomers is closely adjacent if not su-
perimposed to that recognizing folding species (24). Probably
GT inserts a portion of the N-terminal domain, normally buried
in the N-terminal/C-terminal domain interphase, into the sub-
strate native hydrophobic core. This interaction would cease
when the final side chain packing of the core is attained, giving
place to the stable and consolidated final structure. Experi-
ments to address these issues through spectroscopic methods
are in progress.
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